GSK2126458 has the potential to inhibit the proliferation of pancreatic cancer uncovered by bioinformatics analysis and pharmacological experiments
Crossref DOI link: https://doi.org/10.1186/s12967-021-03050-7
Published Online: 2021-08-30
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Feng, Yueqin
Jiang, Yuguan
Hao, Fengjin
Text and Data Mining valid from 2021-08-30
Version of Record valid from 2021-08-30
Article History
Received: 21 May 2021
Accepted: 24 August 2021
First Online: 30 August 2021
Declarations
:
: None.
: The authors declare that they have no conflict of interest.